Your session is about to expire
← Back to Search
Behavioural Intervention
TMS for PTSD (rTMS for PTSD Trial)
N/A
Recruiting
Led By Bradley V Watts, MD MPH
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age between 19 and 70
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
rTMS for PTSD Trial Summary
This trial is testing whether transcranial magnetic stimulation, a treatment for depression, is also effective for treating PTSD in veterans.
Who is the study for?
This trial is for Veterans aged 19-70 with moderate to severe PTSD, eligible for VA healthcare. Participants must not be using certain medications like high-dose bupropion or clozapine, have no metal in their head (except dental work), no major CNS disorders, unstable medical conditions, recent seizures, or current psychosis. Women of childbearing potential must use birth control.Check my eligibility
What is being tested?
The study tests if Transcranial Magnetic Stimulation (TMS), a non-invasive method using magnets to stimulate the brain, can improve functioning in Veterans with PTSD compared to sham TMS. It's randomized and involves 91 participants who either receive real TMS or a placebo-like sham treatment.See study design
What are the potential side effects?
While the description doesn't specify side effects of TMS, common ones include headache, scalp discomfort at the stimulation site during treatment sessions, lightheadedness and rare risk of seizure.
rTMS for PTSD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 19 and 70 years old.
rTMS for PTSD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
CAPS
QIDS SR-16
WHODAS
rTMS for PTSD Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: TMSExperimental Treatment1 Intervention
transcranial magnetic stimulation delivered to the right dorsolateral prefrontal cortex at 1 Hz
Group II: ShamPlacebo Group1 Intervention
sham transcranial magnetic stimulation delivered to the right dorsolateral prefrontal cortex
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,610 Previous Clinical Trials
3,305,093 Total Patients Enrolled
Bradley V Watts, MD MPHPrincipal InvestigatorWhite River Junction VA Medical Center, White River Junction, VT
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have a major brain condition like a stroke, tumor, or epilepsy.You are eligible for VA healthcare.You have a problem with alcohol or drugs that affects your ability to take part in the study.I am between 19 and 70 years old.I have previously used TMS therapy.I am currently taking clozapine or more than 300mg of bupropion daily.I have undergone PTSD therapy using CPT or PE in the last 2 months.You are able to obtain a Motor Threshold using the TMS device during screening.I have had a seizure in the last year.You frequently think about hurting yourself or ending your life.You have a device in your heart called a pacemaker or implantable defibrillator.If female with childbearing potential, use of acceptable method of birth control (i.e., use of contraceptives, abstinence).You have agreed to have your voice recorded for the purpose of being heard by a clinician.You have moderate to severe PTSD.I haven't changed my depression medication in the last 2 months.You are currently experiencing extreme mood swings or hallucinations.
Research Study Groups:
This trial has the following groups:- Group 1: TMS
- Group 2: Sham
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any requirements I should be aware of to join this research?
"This clinical trial is accepting 91 participants who have been diagnosed with PTSD and range in age from 19 to 70."
Answered by AI
To what capacity is this clinical trial accepting patients?
"Confirmative. The clinicaltrials.gov website demonstrates that this research project is currently welcoming participants - it was initially posted on December 1st 2020 and most recently edited on October 20th 2022. It aims to enroll 91 people from a single medical facility."
Answered by AI
Is the enrollment for this clinical research open to seniors over 80?
"Within the scope of this clinical trial, only adults aged 19 to 70 may apply. For those younger than 18 and older than 65 there are other trials that they might be eligible for; 36 trials exist below age 18 while 242 can be found above 65 years old."
Answered by AI
Are there any vacancies left for potential participants in this experiment?
"Affirmative. Clinicaltrial.gov has documentation detailing that this clinical study is actively seeking participants, with the initial post dates back to December 1st 2020 and last edited on October 20th 2022. The research requires 91 individuals from a single medical centre for successful completion."
Answered by AI
Who else is applying?
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger